Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial

Quitting smoking is the most important element in the therapeutic management of chronic respiratory diseases. Combining pharmacotherapy with behavioral support increases smoking cessation success rates. In addition, hospitalized smokers have increased motivation to quit. We investigated the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Politis, Alexios, Ioannidis, Vasileios, Gourgoulianis, Konstantinos I, Daniil, Zoe, Hatzoglou, Chrissi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958473/
https://www.ncbi.nlm.nih.gov/pubmed/29117796
http://dx.doi.org/10.1177/1479972317740128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958473/
https://www.ncbi.nlm.nih.gov/pubmed/29117796
http://dx.doi.org/10.1177/1479972317740128

Ejemplares similares